Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Wound healing is a complex process involving different cells and stages, leading to scar tissue formation and strength increase over time.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Lupus can cause hair loss and nail changes, with treatments available for both.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Dermatologists should customize cosmetic treatments for dark-skinned patients to minimize risks and complications.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Finasteride may cause gum side effects in some patients.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.